The rodent amygdala contributes to the production of cannabinoid-induced antinociception

Neuroscience

Volumn 120, Issue 4, 2003, Pages 1157-1170

  Manning, B H ^a   Martin, W J ^a   Meng, I D ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amygdaloid complex; Analgesia; c fos; Fos; Muscimol; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; CANNABINOID; FORMALDEHYDE; MUSCIMOL; PROTEIN C FOS; WIN 55 212 2;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHESUS MONKEY; SPINAL CORD DORSAL HORN; TAIL FLICK TEST; TEMPORAL LOBE;

EID: 0042634264     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00356-7     Document Type: Article

References (69)

1. Abbadie C., Besson J.M. Effects of morphine and naloxone on basal and evoked Fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats. Pain. 52:1993;29-39.
2. Abbott F.V., Franklin K.B.J., Westbrook R.F. The formalin test scoring properties of the first and second phases of the pain response in rats . Pain. 60:1995;91-102.
3. Aggleton J.P. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 16:1993;328-333.
4. Amaral DG, Price JL, Pitkanen A, Carmichael ST (1992) Anatomical organization of the primate amygdaloid complex. In: The amygdala: neurobiological aspects of emotion, memory and mental dysfunction (Aggleton JP, ed), pp 1-66. New York: Wiley-Liss.
5. Antal M., Petko M., Polgar E., Heizmann C.W., Storm-Mathisen J. Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla. Neuroscience. 73:1996;509-518.
6. Bellgowan P.S., Helmstetter F.J. Neural systems for the expression of hypoalgesia during nonassociative fear. Behav Neurosci. 110:1996;727-736.
7. Bernard J.F., Bester H., Besson J.M. Involvement of the spino-parabrachio-amygdaloid and -hypothalamic pathways in the autonomic and affective emotional aspects of pain. Prog Brain Res. 107:1996;243-255.
8. Bernard J.F., Huang G.F., Besson J.M. Nucleus centralis of the amygdala and the globus pallidus ventralis electrophysiological evidence for an involvement in pain processes . J Neurophysiol. 68:1992;551-569.
9. Bitner R.S., Nikkel A.L., Curzon P., Arneric S.P., Bannon A.W., Decker M.W. Role of the nucleus raphe magnus in antinociception produced by ABT-594 immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons . J Neurosci. 18:1998;5426-5432.
10. Burkey A.R., Carstens E., Wenniger J.J., Tang J., Jasmin L. An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception. J Neurosci. 16:1996;6612-6623.
11. Cichewicz D.L., Martin Z.L., Smith F.L., Welch S.P. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol dose-response analysis and receptor identification . J Pharmacol Exp Ther. 289:1999;859-867.
12. Coderre T.J., Fundytus M.E., McKenna J.E., Dalal S., Melzack R. The formalin test a validation of the weighted-scores method of behavioural pain rating . Pain. 54:1993;43-50.
13. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J Pharmacol. 72:1941;74-79.
14. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry. 44:1998;1239-1247.
15. Davis M., Whalen P.J. The amygdala vigilance and emotion . Mol Psychiatry. 6:2001;13-34.
16. Dielenberg R.A., McGregor I.S. Defensive behavior in rats towards predatory odors a review . Neurosci Biobehav Rev. 25:2001;597-609.
17. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol. 367:1996;375-402.
18. Egertova M., Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol. 422:2000;159-171.
19. Emery N.J., Amaral D.G. The role of the amygdala in primate social cognition. Lane R.D., Nadel L. Cognitive neuroscience of emotion. 2000;156-191 Oxford University Press, New York.
20. Farquhar-Smith W.P., Egertova M., Bradbury E.J., McMahon S.B., Rice A.S., Elphick M.R. Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci. 15:2000;510-521.
21. Fields H.L., Basbaum A.I. Central nervous system mechanisms of pain modulation. Wall P.D., Melzack R. Textbook of pain. 1999;243-257 Churchill Livingstone, Edinburgh.
22. Fox R.J., Sorenson C.A. Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges. Brain Res. 648:1994;215-221.
23. Hammond D.L., Presley R., Gogas K.R., Basbaum A.I. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J Comp Neurol. 315:1992;244-253.
24. Harris J.A., Westbrook R.F. Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. Behav Neurosci. 109:1995;295-304.
25. Helmstetter F.J. The amygdala is essential for the expression of conditional hypoalgesia. Behav Neurosci. 106:1992;518-528.
26. Helmstetter F.J., Bellgowan P.S. Lesions of the amygdala block conditional hypoalgesia on the tail flick test. Brain Res. 612:1993;253-257.
27. Helmstetter F.J., Bellgowan P.S., Tershner S.A. Inhibition of the tail flick reflex following microinjection of morphine into the amygdala. Neuroreport. 4:1993;471-474.
28. Hirakawa N., Tershner S.A., Fields H.L., Manning B.H. Bi-directional changes in affective state elicited by manipulation of medullary pain-modulatory circuitry. Neuroscience. 100:2000;861-871.
29. Holland P.C., Gallagher M. Amygdala circuitry in attentional and representational processes. Trends Cogn Sci. 3:1999;65-73.
30. LeDoux J.E. Emotion clues from the brain . Annu Rev Psychol. 46:1995;209-235.
31. Lee H.J., Choi J.S., Brown T.H., Kim J.J. Amygdalar NMDA receptors are critical for the expression of multiple conditioned fear responses. J Neurosci. 21:2001;4116-4124.
32. Lichtman A.H., Martin B.R. Spinal action of cannabinoid-induced antinociception. NIDA Res Monogr. 105:1991;422-424.
33. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J Pharmacol Exp Ther. 258:1991;517-523.
34. Lichtman A.H., Martin B.R. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacol Biochem Behav. 57:1997;7-12.
35. Manning B.H. A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala. J Neurosci. 18:1998;9453-9470.
36. Manning B.H., Franklin K.B.J. Morphine analgesia in the formalin test reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray . Behav Brain Res. 92:1998;97-102.
37. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test. Pain. 63:1995;141-152.
38. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J Neurosci. 15:1995;8199-8213.
39. Manning B.H., Merin N.M., Meng I.D., Amaral D.G. Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. J Neurosci. 21:2001;8238-8246.
40. Manning B.H., Morgan M.J., Franklin K. Morphine analgesia in the formalin test evidence for forebrain and midbrain sites of action . Neuroscience. 63:1994;289-294.
41. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS. J Chem Neuroanat. 8:1995;283-305.
42. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci. 11:1999;4213-4225.
43. Martin J.H. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neurosci Lett. 127:1991;160-164.
44. Martin W.J., Coffin P.O., Attias E., Balinsky M., Tsou K., Walker J.M. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res. 822:1999;237-242.
45. Martin W.J., Loo C.M., Basbaum A.I. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain. 82:1999;199-205.
46. Martin W.J., Patrick S.L., Coffin P.O., Tsou K., Walker J.M. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci. 56:1995;2103-2109.
47. Martin W.J., Tsou K., Walker J.M. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci Lett. 242:1998;33-36.
48. Mayer D.J., Manning B.H. The role of opioid peptides in environmentally-induced analgesia. Tseng L.F. The pharmacology of opioid peptides. 1995;345-395 Harwood Academic Publishers, Chur, Switzerland.
49. McGaraughty S., Heinricher M.M. Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity. Pain. 96:2002;153-162.
50. Meng I.D., Manning B.H., Martin W.J., Fields H.L. An analgesia circuit activated by cannabinoids. Nature. 395:1998;381-383.
51. Moldrich G., Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain an immunohistochemical study . Peptides. 21:2000;1735-1742.
52. Morisset V., Ahluwalia J., Nagy I., Urban L. Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur J Pharmacol. 429:2001;93-100.
53. Neugebauer V., Li W. Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input. J Neurophysiol. 87:2002;103-112.
54. Ong W.Y., Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience. 92:1999;1177-1191.
55. Ong W.Y., Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol. 28:1999;39-45.
56. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1997;Academic Press, New York.
57. Pettit D.A., Harrison M.P., Olson J.M., Spencer R.F., Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res. 51:1998;391-402.
58. Presley R.W., Menetrey D., Levine J.D., Basbaum A.I. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci. 10:1990;323-335.
59. Price D.D. Psychological mechanisms of pain and analgesia. 1999;IASP Press, Seattle, WA.
60. Rainville P., Duncan G.H., Price D.D., Carrier B., Bushnell M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 277:1997;968-971.
61. Rhudy J.L., Meagher M.W. Fear and anxiety divergent effects on human pain thresholds . Pain. 84:2000;65-75.
62. Salio C., Fischer J., Franzoni M.F., Mackie K., Kaneko T., Conrath M. CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport. 12:2001;3689-3692.
63. Sañudo-Peña M.C., Strangman N.M., Mackie K., Walker J.M., Tsou K. CB1 receptor localization in rat spinal cord and roots, dorsal root ganglion, and peripheral nerve. Zhongguo Yao Li Xue Bao. 20:1999;1115-1120.
64. Schulz S., Schreff M., Koch T., Zimprich A., Gramsch C., Elde R., Hollt V. Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience. 82:1998;613-622.
65. Tershner S.A., Helmstetter F.J. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray. Brain Res. 865:2000;17-26.
66. Traub R.J., Stitt S., Gebhart G.F. Attenuation of c-Fos expression in the rat lumbosacral spinal cord by morphine or tramadol following noxious colorectal distention. Brain Res. 701:1995;175-182.
67. Tsou K., Brown S., Sañudo-Peña M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 83:1998;393-411.
68. Tsou K., Lowitz K.A., Hohmann A.G., Martin W.J., Hathaway C.B., Bereiter D.A., Walker J.M. Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience. 70:1996;791-798.
69. Willis W.D., Westlund K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol. 14:1997;2-31.